Chris Sampson is a postgraduate researcher in health economics.
He studied BA Economics and MSc Economics & Health Economics at the University of Sheffield, graduating in 2011. He is currently studying for a PhD investigating ways of optimising the cost-effectiveness of risk-based screening programmes.
Chris's expertise lie primarily in the use of economic evaluation alongside clinical trials. He has worked on numerous studies of this kind, being involved at all stages from conception to completion. Clinical areas in which Chris has experience include depression, stroke and diabetic eye disease. This work has seen him apply a variety of methodologies including decision modelling and meta-analysis.
Chris has taught on a number of doctoral training courses, primarily on the topic of decision modelling for economic evaluation in health care.
Chris's current role is linked to a programme of research evaluating the cost-effectiveness of risk-based screening for diabetic retinopathy. His work also extends to a number of other economic… read more
CHRISTOPHER JAMES SAMPSON and TIM WRIGHTSON, 2017. Model registration: a call to action PharmacoEconomics - Open. 1(2), 73-77 SAMPSON, C J, JAMES, M, BROADBENT, D M and HARDING, S P, 2016. Stratifying the NHS Diabetic Eye Screening Programme: into the unknown? Diabetic Medicine.
MORRISS R, GARLAND A, NIXON N, GUO B, JAMES M, KAYLOR-HUGHES C, MOORE R, RAMANA R, SAMPSON C, SWEENEY T, DALGLEISH T and NIHR CLAHRC SPECIALIST MOOD DISORDER STUDY GROUP, 2016. Efficacy and cost-effectiveness of a specialist depression service versus usual specialist mental health care to manage persistent depression: a randomised controlled trial The Lancet Psychiatry.